The National Institutes of Health will hold a virtual meeting and listening session on the United States government’s Oversight Framework for Research Involving Enhanced Potential Pandemic Pathogens (ePPPs).
In 2017, the federal government developed a comprehensive framework to help preserve the benefits of critical life sciences research while minimizing the potential biosafety and biosecurity risks of ePPP research. In February 2022, the Acting NIH Director charged the National Science Advisory Board for Biosecurity (NSABB) to review the scope and effectiveness of this framework.
The purpose of this meeting is to get input from a wide range of stakeholders on the scope of the framework, strategies for minimizing potential biosafety and biosecurity risks, considerations for supporting international ePPP research and how to balance security with public transparency. Members of the public will be given the opportunity to register to speak at the meeting. Additionally, input from this listening session will help inform the deliberations and policy recommendations of the NSABB related to its current charge.
Wednesday, April 27, 2022, 12:00-3:00 p.m. EDT
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®